enVVeno Medical (NVNO) Gains from Sales and Divestitures (2020 - 2022)

enVVeno Medical has reported Gains from Sales and Divestitures for 3 years, with the latest figure at $2082.0 in Q4 2022.

• For the quarter ending Q4 2022, Gains from Sales and Divestitures fell 99.93% year-over-year to $2082.0; the trailing twelve-month figure through Dec 2022 stood at $2082.0 (down 99.93% YoY), and the FY2022 full-year result was $2082.0, down 99.93% from the prior year.
• Gains from Sales and Divestitures for Q4 2022 stood at $2082.0, down from $2.9 million in the prior quarter.
• The five-year high for Gains from Sales and Divestitures was $2.9 million in Q4 2021, with the low at $2082.0 in Q4 2022.
• Average Gains from Sales and Divestitures over 3 years is $958315.3, with a median of $12864.0 recorded in 2020.
• Year-over-year, Gains from Sales and Divestitures soared 22132.59% in 2021 and plunged 99.93% in 2022.
• Tracing NVNO's Gains from Sales and Divestitures over 3 years: stood at $12864.0 in 2020, then soared by 22132.59% to $2.9 million in 2021, then sank by 99.93% to $2082.0 in 2022.
• The last three Gains from Sales and Divestitures figures came in at $2082.0 (Q4 2022), $2.9 million (Q4 2021), and $12864.0 (Q4 2020), per Business Quant data.

Peer Comparison